The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis

Radical cure of Plasmodium vivax malaria in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals employs weekly primaquine dosing. This is the only recommended regimen for this patient sub-group. If national malaria programs mandate daily primaquine dosing (the recommended regimen for G6PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Cindy S., Bancone, Germana, Soe, Nay Lin, Carrara, Verena I., Gornsawun, Gornpan, Nosten, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Clinical Practice Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480970/
https://www.ncbi.nlm.nih.gov/pubmed/31069260
http://dx.doi.org/10.12688/wellcomeopenres.15100.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480970/
https://www.ncbi.nlm.nih.gov/pubmed/31069260
http://dx.doi.org/10.12688/wellcomeopenres.15100.2

Ejemplares similares